About Jay
Jay Lefton practices corporate and securities law. Jay advises clients on public and private mergers & acquisitions transactions, private equity matters and public and private financings, as well as assisting with strategic alliances, technology transfer and licensing. He works predominantly in the technology and life sciences sector.Assisting acquirers and target companies and their boards of directors, Jay advises on negotiated transactions and unsolicited takeover bids, most of which are multi-jurisdictional.Jay also represents issuers, both public and private, as well as advisers, venture capitalists, institutional investors and private equity funds. Working with universities, hospitals, research institutions and researchers, Jay advises at various stages in the commercialization of their discoveries.
Jay Lefton practices corporate and securities law. Jay advises clients on public and private mergers & acquisitions transactions, private equity matters and public and private financings, as well as assisting with strategic alliances, technology transfer and licensing. He works predominantly in the technology and life sciences sector.Assisting acquirers and target companies and their boards of directors, Jay advises on negotiated transactions and unsolicited takeover bids, most of which are multi-jurisdictional.Jay also represents issuers, both public and private, as well as advisers, venture capitalists, institutional investors and private equity funds. Working with universities, hospitals, research institutions and researchers, Jay advises at various stages in the commercialization of their discoveries.
Jay Lefton practices corporate and securities law. Jay advises clients on public and private mergers & acquisitions transactions, private equity matters and public and private financings, as well as assisting with strategic alliances, technology transfer and licensing. He works predominantly in the technology and life sciences sector.
Assisting acquirers and target companies and their boards of directors, Jay advises on negotiated transactions and unsolicited takeover bids, most of which are multi-jurisdictional.
Jay also represents issuers, both public and private, as well as advisers, venture capitalists, institutional investors and private equity funds. Working with universities, hospitals, research institutions and researchers, Jay advises at various stages in the commercialization of their discoveries.
